Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) Return on Capital Employed (2022 - 2025)

CervoMed (CRVO) has disclosed Return on Capital Employed for 7 consecutive years, with 1.28% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 85.0% to 1.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.28% through Dec 2025, down 85.0% year-over-year, with the annual reading at 1.0% for FY2025, 19.0% down from the prior year.
  • Return on Capital Employed hit 1.28% in Q4 2025 for CervoMed, down from 0.43% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.29% in Q1 2022 to a low of 1.28% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 0.6% across 3 years, with a median of 0.49% in 2022.
  • Biggest YoY gain for Return on Capital Employed was -85bps in 2025; the steepest drop was -85bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.52% in 2022, then increased by 17bps to 0.43% in 2024, then crashed by -196bps to 1.28% in 2025.
  • Business Quant data shows Return on Capital Employed for CRVO at 1.28% in Q4 2025, 0.43% in Q4 2024, and 0.52% in Q3 2022.